[1]周小玲,章新友,仵倚,等.“互联网+”中医药的SWOT分析与对策[J].医学争鸣,2017,(05):45-48.[doi:10.13276/j.issn.1674-8913.2017.05.013]
 ZHOU Xiao-Ling,ZHANG Xin-You,WU Yi,et al.SWOT analysis and countermeasures of “Internet plus” traditional Chinese medicine[J].,2017,(05):45-48.[doi:10.13276/j.issn.1674-8913.2017.05.013]
点击复制

“互联网+”中医药的SWOT分析与对策

相似文献/References:

[1]彭恩胜,陈江勇.影响中医药文化核心价值体系建设的若干维度[J].医学争鸣,2014,(03):28.
 PENG En-Sheng,CHEN Jiang-Yong.Multiple dimensional analysis about the construction of TCM culture core-value system[J].,2014,(05):28.
[2]唐汉庆.中医药转化医学研究实验室建设面临的问题及对策[J].医学争鸣,2014,(03):32.
 TANG Han-Qing.Problems and solutions of constructing laboratory of translational Chinese medicine[J].,2014,(05):32.
[3]张伯礼.面向未来:世界需要中医药[J].医学争鸣,2016,(01):1.[doi:10.13276/j.issn.1674-8913.2016.01.001]
 ZHANG Bo-Li.For the future: the world needs Traditional Chinese Medicine[J].,2016,(05):1.[doi:10.13276/j.issn.1674-8913.2016.01.001]
[4]毕礼明,陈英兰,奉典旭.转化医学与中医防治肾脏病研究策略[J].医学争鸣,2016,(05):38.[doi:10.13276/j.issn.1674-8913.2016.05.011]
 BI Li-Ming,CHEN Ying-Lan,FENG Dian-Xu.Translational medicine and research strategies of renaldisease prevention and therapy with Chinese medicine[J].,2016,(05):38.[doi:10.13276/j.issn.1674-8913.2016.05.011]
[5]蔡燕峰,金小晶.中药+质子泵抑制剂:根除幽门螺杆菌治疗 的新方案探讨[J].医学争鸣,2017,(04):62.[doi:10.13276/j.issn.1674-8913.2017.04.017]
 CAI Yan-Feng,JIN Xiao-Jing.Chinese medicine plus proton pump inhibitor: a new Helicobacter pylori eradication scheme[J].,2017,(05):62.[doi:10.13276/j.issn.1674-8913.2017.04.017]
[6]陈 哲,李惠林,李增英,等.“miRNA—肾主骨—骨质疏松”相关性假说[J].医学争鸣,2018,(06):28.[doi:10.13276/j.issn.1674-8913.2018.06.008]
 CHEN Zhe,LI Huilin,LI Zengying,et al.A correlation hypothesis of “miRNA-kidney dominating bones-osteoporosis”[J].,2018,(05):28.[doi:10.13276/j.issn.1674-8913.2018.06.008]
[7]谢子妍,由凤鸣,金 钊,等.口腔微生物移位定植——中医药干预结肠炎癌转化新窗口[J].医学争鸣,2018,(06):48.[doi:10.13276/j.issn.1674-8913.2018.06.014]
 XIE Ziyan,YOU Fengming,JIN Zhao,et al.Oral microorganism transplantation/colonization —New consideration of traditional Chinese medicine intervention in IBD-CRC[J].,2018,(05):48.[doi:10.13276/j.issn.1674-8913.2018.06.014]
[8]王诗源,菅广峰,陈莉军,等.中医药健康旅游产业发展存在的问题及对策[J].医学争鸣,2019,(01):15.[doi:10.13276/j.issn.1674-8913.2019.01.005]
 WANG Shiyuan,JIAN Guangfeng,CHEN Lijun,et al.Problems and countermeasures in the development of traditional Chinese medicine health tourism industry[J].,2019,(05):15.[doi:10.13276/j.issn.1674-8913.2019.01.005]
[9]周亮亮,田 侃,姚银蓥.“互联网+”背景下我国处方药网络销售的路径探析[J].医学争鸣,2019,(03):68.[doi:10.13276/j.issn.1674-8913.2019.03.017]
 ZHOU Liangliang,TIAN Kan,YAO Yinying.Path analysis of Chinese prescription drug sale online against the background of “Internet +”[J].,2019,(05):68.[doi:10.13276/j.issn.1674-8913.2019.03.017]
[10]冷玉琳,富晓旭,唐诗韵,等.基于精准医学探讨中医药防治糖尿病及 其并发症策略[J].医学争鸣,2019,(04):52.[doi:10.13276/j.issn.1674-8913.2019.04.012]
 LENG Yulin,FU Xiaoxu,TANG Shiyun,et al.TCM prevention and treatment strategies of diabetes and its complications based on precision medicine[J].,2019,(05):52.[doi:10.13276/j.issn.1674-8913.2019.04.012]

备注/Memo

基金项目:国家自然科学基金(81660727);江西省教育厅科学技术研究项目( GJJ150881)
通讯作者:章新友。Tel:13607006236, E-mail:xinyouzhang@163.com
作者简介:周小玲。硕士生(导师章新友)。研究方向:中医药信息学。Tel:18942351211,E-mail:1084198181@qq.com

更新日期/Last Update: 2017-08-20